Finplate

ESCO Technologies (NYSE:ESE) is making a big move by acquiring Ultra Maritime's Signature Management & Power business for $550M, boosting its aerospace and defense segment. Funded through cash and new loans, this strategic purchase is expected to add $175M in revenue by 2024. #BusinessAcquisition #Aerospace #DefenseIndustry #StrategicGrowth

NEWS OF THE DAY! ESCO Technologies Boosts Defense Segment with $550M Acquisition, Eyes $175M Revenue Growth in 2024 1. ESCO Technologies is buying Signature Management & Power from Ultra Maritime for $550 million. 2. The purchase will be paid for using cash and additional debt, with financing already arranged. 3. The new business will join ESCO's aerospace and defense segment. 4. It is expected to bring in about $175 million in revenue in 2024. =>Please follow Finplate and stay updated with the latest mergersandacquisitions news. Thanks in advance. To read the news in detail, click below: https://lnkd.in/gcXX8_CU

SM Energy Company is in advanced talks to acquire Utah-based oil and gas producer XCL Resources for around $3 billion. This deal, expected to be announced soon, will expand SM Energy's operations into the Uinta Basin, known for its lubricant-producing waxy oil, adding to their existing Texas operations in the Eagle Ford and Midland basins. #OilAndGas #Acquisition #SMEnergy #XCLResources #EnergyExpansion #UintaBasin

NEWS OF THE DAY! SM Energy Company Eyes $3 Billion Expansion with XCL Resources Acquisition, Boosting Uinta Basin Presence 1. SM Energy (NYSE:SM) is in advanced discussions to buy XCL Resources, a Utah-based oil and gas company. 2. The potential deal values XCL Resources at approximately $3 billion. 3. An announcement about the deal could happen soon, involving XCL's backers, including EnCap Investments. 4. If finalized, the acquisition would expand SM Energy's operations into the Uinta Basin. 5. The Uinta Basin produces a special waxy oil used in lubricants. 6. Currently, SM Energy operates mainly in the Eagle Ford and Midland basins in Texas. =>Please follow Finplate and stay updated with the latest mergersandacquisitions news. Thanks in advance. To read the news in detail, click below: https://lnkd.in/gEnA6ZPC

Shift4 has taken a major step in expanding its European footprint by acquiring a majority stake in Vectron, adding 65,000 new POS locations, local expertise, and a robust distribution network. Additionally, Shift4 completed its acquisition of Revel Systems, reinforcing its position in the POS market. Stay tuned for more growth as they plan to further increase their stake in Vectron soon! #BusinessExpansion #POSSystems #Shift4 #Vectron #RevelSystems #MarketGrowth #TechAcquisition

NEWS OF THE DAY! Shift4's Bold Move: Acquires Majority Stake in Vectron, Expanding to 65,000 POS Locations Across Europe 1. Shift4 acquired a majority stake in Vectron, gaining access to 65,000 point-of-sale (POS) locations in Europe. 2. Vectron brings local product expertise and a European distribution network of 300 POS resellers to Shift4. 3. Shift4 plans to acquire more of Vectron through a public tender offer, expected to finish within a month, followed by delisting and integration. 4. Shift4 has also completed its acquisition of Revel Systems. =>Please follow Finplate and stay updated with the latest mergersandacquisitions news. Thanks in advance. To read the news in detail, click below: https://lnkd.in/gGtcH2Ky

PENN Entertainment, Inc's stock tumbled 8.2% after an analyst downplayed the chances of a strategic review, despite recent speculation of a potential sale that had boosted shares. The analyst highlighted Penn's strong ESPN Bet roadmap, the upcoming football season, and volatile interest rates as reasons against a review. With Penn being highly efficient, there's little room for easy gains through mergers. Earlier, rumors of Boyd Gaming's interest in Penn had lifted the stock. #StockMarket #PennEntertainment #GamingIndustry #MergersAndAcquisitions #ESPNBet

NEWS OF THE DAY! PENN Entertainment, Inc's Stock Tumbles 8%: Analyst's Bold Prediction Shakes Market 1. Penn Stock Drops 8.2% After Analyst Comments    Analyst says no near-term strategic review expected. 2. Shares Previously Soared 20% on May 31    Activist Donerail Group suggested potential sale doubling stock price. 3. Analyst Cites ESPN Bet and Football Season    Strategic review unlikely due to clear product roadmap. 4. Impact of High and Volatile Interest Rates    Interest rates affecting overall M&A activities. 5. Efficient Land-Based Operations    Penn's efficiency limits operational synergy opportunities. 6. Buy Rating Maintained with Higher Price Target    Analyst raises price target from $23 to $25. 7. Stock Jumped 7% Amid Boyd Gaming Speculation    Boyd Gaming's new director fuels acquisition speculation. =>Please follow Finplate and stay updated with the latest mergersandacquisitions news. Thanks in advance. To read the news in detail, click below: https://lnkd.in/g7gaiU6K

Cerevel Therapeutics' stock seesaws as investors fret over an upcoming Federal Trade Commission meeting that might impact AbbVie's $8.7 billion acquisition deal. Despite the jitters, AbbVie assures progress. Meanwhile, the FTC gears up for potential action against Southern Glazer's. Stay tuned for more developments! #StockMarket #PharmaDeals #FTC #Investing #MergersAndAcquisitions

NEWS OF THE DAY! Federal Trade Commission's Critical Meeting Puts AbbVie's $8.7 Billion Cerevel Therapeutics Deal in the Spotlight 1. Stock Movements: Cerevel Therapeutics' shares fluctuated, rising by 0.7% after initially falling by 0.6%. 2. FTC Meeting: The Federal Trade Commission (FTC) announced a closed-door meeting for next Thursday at 12:30 pm to discuss a nonpublic law enforcement matter. 3. Investor Concerns: Investors are worried the FTC might vote on AbbVie's $8.7 billion acquisition of Cerevel. 4. Possible Focus: These FTC meetings can involve either public or private companies. 5. Related FTC Activity: The FTC is reportedly preparing to sue Southern Glazer’s Wine and Spirits over pricing practices. 6. AbbVie’s Reassurance: AbbVie's COO assured investors that progress is being made with the FTC regarding the Cerevel acquisition, expecting to close the deal mid-year. 7. FTC Requests: In February, the FTC requested additional information from AbbVie and Cerevel about their deal, originally announced in December for $45 per share, totaling approximately $8.7 billion in cash. =>Please follow Finplate and stay updated with the latest mergersandacquisitions news. Thanks in advance. To read the news in detail, click below: https://lnkd.in/gYnfavCQ